Aesthetic Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Pages: 537 Published: October 27, 2022 Report Code: GDME1459EPD
- Share on Twitter
- Share on LinkedIn
- Share on Facebook
- Share via Email
- Copy Link
The Aesthetic Devices pipeline market research report provides comprehensive information about the Aesthetic Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aesthetic Devices Pipeline Products Market Segmentation, by Territories
Some of the key territories with products in the pipeline are the US, Europe, China, South Korea, Canada, Australia, Israel, Singapore, Brazil, and Japan. As of October 2022, the US has the highest number of products in the pipeline out of them all.
Aesthetic Devices Pipeline Products Market Analysis, by Territories, 2022 (%)
For more territory insights into Aesthetic Devices pipeline products market, download a free report sample
Aesthetic Devices Pipeline Products Market by Key Segments
Some of the key segments in the aesthetic devices pipeline products market are hyaluronic acid fillers, aesthetic injectables, aesthetic laser, implants, dermal filler, non-invasive body contouring devices, breast implants, shaped gel implants, high intensity focused ultrasound (HIFU) devices, and acne device. Hyaluronic acid fillers have the greatest number of products in the pipeline.
Aesthetic Devices Pipeline Products Market Analysis, by Segments, 2022 (%)
For more aesthetic devices pipeline products market segment insights, download a free report sample
Aesthetic Devices Pipeline Products Market Segmentation by Key Regulatory Paths
Some of the key regulatory paths followed by the aesthetic devices pipeline products market are 510(k), CE, PMA, NMPA, NIFDS, MDL, TGA, MDITAC, HSA, and ANVISA. Most of the products follow the 510(k) pathway to enter the market.
Aesthetic Devices Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)
For more Aesthetic Devices pipeline regulatory path insights, download a free report sample
Competitive Landscape
Some of the key companies in the aesthetic devices pipeline products market are 3D Bio Corp, AbbVie Inc, Accure Acne Inc, Acoustiic Inc, Acro Biomedical Co Ltd, Advanced Aesthetic Technologies Inc, Aeon Astron Corporation, Aesthetic Medical Device, Aesthetics BioMedical, Inc., and Aesthetics Point Ltd.
3D Bio Corp: It operates as a biotechnology company that specializes in regenerative medicine and devices. The company provides a bioprinting platform that focuses on whole-tissue living implants for near-term indications. The company is headquartered in New York, the US.
AbbVie Inc: It is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. AbbVie is also advancing its pipeline programs for the treatment of cystic fibrosis, women’s health, various cancers, neurological disorders and other autoimmune diseases. The company markets its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies, and independent retailers through its own distribution centers and public warehouses worldwide. AbbVie is headquartered in North Chicago, Illinois, the US.
Accure Acne, Inc: It is a medical device company that is engaged in developing a novel and impactful solution for acne sufferers that employs revolutionary technology. The company is headquartered in the US.
Aesthetic Devices Pipeline Products Market Report Overview
Key Territories | The US, Europe, China, South Korea, Canada, Australia, Israel, Singapore, Brazil, and Japan |
Key Segments | Hyaluronic Acid Fillers, Aesthetic Injectables, Aesthetic Laser, Implants, Dermal Filler, Non-Invasive Body Contouring Devices, Breast Implants, Shaped Gel Implants, High Intensity Focused Ultrasound (HIFU) Devices, and Acne Device |
Key Regulatory Paths | 510(k), CE, PMA, NMPA, NIFDS, MDL, TGA, MDITAC, HSA, and ANVISA |
Key Companies | 3D Bio Corp, AbbVie Inc, Accure Acne Inc, Acoustiic Inc, Acro Biomedical Co Ltd, Advanced Aesthetic Technologies Inc, Aeon Astron Corporation, Aesthetic Medical Device, Aesthetics BioMedical, Inc., and Aesthetics Point Ltd |
Segments Covered in the Report
Aesthetic Devices Pipeline Products Market Territories Outlook
- The US
- Europe
- China
- South Korea
- Canada
- Australia
- Israel
- Singapore
- Brazil
- Japan
Aesthetic Devices Pipeline Products Market Segments Outlook
- Hyaluronic Acid Fillers
- Aesthetic Injectables
- Aesthetic Laser
- Implants
- Dermal Filler
- Non-Invasive Body Contouring Devices
- Breast Implants
- Shaped Gel Implants
- High Intensity Focused Ultrasound (HIFU) Devices
- Acne Device
Aesthetic Devices Pipeline Products Market Regulatory Paths Outlook
- 510(k)
- CE
- PMA
- NMPA
- NIFDS
- MDL
- TGA
- MDITAC
- HAS
- ANVISA
Scope
This report provides:
- Extensive coverage of the Aesthetic Devices under development.
- Details of major pipeline products which include product description, licensing, collaboration details, and other developmental activities.
- Reviews of the major players involved in the development of Aesthetic Devices and lists all their pipeline projects.
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
- Identify and understand important and diverse types of Aesthetic Devices under development.
- Develop market-entry and market expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Key Players
AbbVie Inc
Accure Acne Inc
Acoustiic Inc
Acro Biomedical Co Ltd
Advanced Aesthetic Technologies Inc
Aeon Astron Corporation
Aesthetic Medical Device
Aesthetics BioMedical, Inc.
Aesthetics Point Ltd.
AirXpanders, Inc.
Allergan Aesthetics
Almirall Ltd
Ambicare Health Ltd
AngioDynamics Inc
Apex Medical Device Design LLC
Apyx Medical Corp
Arula Technolgies
Asymmetric Medical Ltd
Bausch Health Companies Inc
Becton Dickinson and Co
Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd
Beijing MeiYan KongJian Technology Co Ltd
BellaSeno GmbH
BellaSeno Pty Ltd
Bimini Health Technologies
BioPlus Co Ltd
Biosculpture Technology, Inc.
Biostruxs LLC
Bioxis Pharmaceuticals
BMG Pharma SpA
Bmi Korea Co Ltd
Boston Scientific Corp
Candela Corp
CellPraxis
Celltrix AB
Clearbridge Health Ltd
ClearIt LLC
Collplant Biotechnologies Ltd
Cutera Inc
Cytrellis Biosystems Inc
Delft University of Technology
Dexlevo Inc
Emory University
EP Global Communications Inc (Inactive)
Erchonia Corp
Establishment Labs SA
Eternity Healthcare Inc
EternoGen Aesthetics LLC
Fillmed Laboratoires
FixNip Ltd
Florida International University
Forticell Bioscience Inc
Fourth State Medicine Ltd
G2GBIO Inc
Galderma SA
GC Aesthetics Plc
Genial Light Co Ltd
Genzyme Corp
Giant Biogene Holding Co Ltd
Hallura Ltd
HansBiomed Co Ltd
Healshape SAS
Histogen Inc
Hugel Inc
Ilooda Co Ltd
ImpLite Ltd.
InMode Ltd
Innova Medical Design
Innovia LLC
Intuitive Surgical Inc
Inventage Lab Inc
Jointechlabs Inc
Juvenis Ltd
Khorionyx SA
Lattice Medical
LG Chem Ltd
LifeCell Corp
LifeSprout Inc
LigthSense Israel Ltd
Lineage Cell Therapeutics Inc
ManaMed Inc
Medality Medical LLC
Medifirst Solutions Inc
Medytox Inc
Mentor Worldwide LLC
Merz North America Inc
Merz Pharma GmbH & Co KgaA
Mesoestetic Pharma Group SL
Moma Therapeutics Inc
N8 Medical LLC
NanoVibronix Inc
Neosthetic, LLC
NivaSonix, LLC
Northwestern University
Nu Skin International Inc.
Oligo Medic Inc
Oxtex Ltd (Inactive)
Pantec Biosolutions AG
PB&B SA
PetVivo Holdings Inc
Philips Healthcare
PhotoDerma SA
PhotoMedex Inc
PhotoSonix Medical, Inc.
Pinnacle Therapeutics
Plcoskin
PolyNovo Biomaterials Pty Ltd
Pongkece (Shanghai) Intelligent Medical Technology Co Ltd
Prayasta 3D Inventions Pvt Ltd
PS Advanced Engineering
Q-Med AB
Recros Medica Inc
Revance Therapeutics Inc
Samyang Biopharmaceuticals Corp
SANUWAVE Health Inc
Sebana Medical Ltd
Shanghai Haohai Biological Technology Co Ltd
Shin Poong Pharm Co Ltd
Sienna Biopharmaceuticals Inc (Inactive)
Sientra Inc
Sihuan Pharmaceutical Holdings Group Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
Slender Medical Ltd.
SMSbiotech Inc
Sofregen Medical Inc
SofWave Medical Ltd
Soliton Inc
Southern Illinois University Carbondale
SunMax Biotechnology Co Ltd
Symatese Aesthetics
TEI Biosciences Inc
Tempo Therapeutics Inc
Tensive SRL
Teoxane SA
Tetratherix Pty Ltd
TeVido BioDevices LLC
Tissue Regeneration Technologies LLC
Tissueform Inc
University of California Irvine
University of California Santa Barbara
University of Missouri
University of Pittsburgh
University of Texas at Austin
Uronext LLC
Venus Concept Inc (Inactive)
Wuhan Tianshiwei Holdings Co Ltd
Zeltiq Aesthetics Inc
Zift Medical LLC
Table of Contents
|1 Table of Contents 3
|1.1 List of Tables 13
|1.2 List of Figures 29
2 Introduction 30
2.1 Aesthetic Devices Overview 30
3 Products under Development 32
3.1 Aesthetic Devices – Pipeline Products by Stage of Development 32
3.2 Aesthetic Devices – Pipeline Products by Segment 33
3.3 Aesthetic Devices – Pipeline Products by Territory 35
3.4 Aesthetic Devices – Pipeline Products by Regulatory Path 37
3.5 Aesthetic Devices – Pipeline Products by Estimated Approval Date 38
3.6 Aesthetic Devices – Ongoing Clinical Trials 39
4 Aesthetic Devices – Pipeline Products under Development by Companies 40
4.1 Aesthetic Devices Companies – Pipeline Products by Stage of Development 40
4.2 Aesthetic Devices – Pipeline Products by Stage of Development 46
5 Aesthetic Devices Companies and Product Overview 53
5.1 3D Bio Corp Company Overview 53
5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 53
5.2 AbbVie Inc Company Overview 54
5.2.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.3 Accure Acne Inc Company Overview 56
5.3.1 Accure Acne Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.4 Acoustiic Inc Company Overview 57
5.4.1 Acoustiic Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.5 Acro Biomedical Co Ltd Company Overview 58
5.5.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
5.6 Advanced Aesthetic Technologies Inc Company Overview 59
5.6.1 Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.7 Aeon Astron Corporation Company Overview 64
5.7.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 64
5.8 Aesthetic Medical Device Company Overview 65
5.8.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 65
5.9 Aesthetics BioMedical, Inc. Company Overview 68
5.9.1 Aesthetics BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.10 Aesthetics Point Ltd. Company Overview 69
5.10.1 Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69
5.11 AirXpanders, Inc. Company Overview 70
5.11.1 AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.12 Allergan Aesthetics Company Overview 71
5.12.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 71
5.13 Almirall Ltd Company Overview 87
5.13.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
5.14 Ambicare Health Ltd Company Overview 88
5.14.1 Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 88
5.15 AngioDynamics Inc Company Overview 89
5.15.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 89
5.16 Apex Medical Device Design LLC Company Overview 90
5.16.1 Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 90
5.17 Apyx Medical Corp Company Overview 91
5.17.1 Apyx Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 91
5.18 Arula Technolgies Company Overview 93
5.18.1 Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 93
5.19 Asymmetric Medical Ltd Company Overview 94
5.19.1 Asymmetric Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.20 Bausch Health Companies Inc Company Overview 95
5.20.1 Bausch Health Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 95
5.21 Becton Dickinson and Co Company Overview 98
5.21.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 98
5.22 Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Company Overview 99
5.22.1 Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
5.23 Beijing MeiYan KongJian Technology Co Ltd Company Overview 100
5.23.1 Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 100
5.24 BellaSeno GmbH Company Overview 103
5.24.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 103
5.25 BellaSeno Pty Ltd Company Overview 106
5.25.1 BellaSeno Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 106
5.26 Bimini Health Technologies Company Overview 109
5.26.1 Bimini Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 109
5.27 BioPlus Co Ltd Company Overview 112
5.27.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112
5.28 Biosculpture Technology, Inc. Company Overview 115
5.28.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.29 Biostruxs LLC Company Overview 117
5.29.1 Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 117
5.30 Bioxis Pharmaceuticals Company Overview 118
5.30.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 118
5.31 BMG Pharma SpA Company Overview 121
5.31.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 121
5.32 Bmi Korea Co Ltd Company Overview 124
5.32.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
5.33 Boston Scientific Corp Company Overview 125
5.33.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 125
5.34 Candela Corp Company Overview 127
5.34.1 Candela Corp Pipeline Products & Ongoing Clinical Trials Overview 127
5.35 CellPraxis Company Overview 128
5.35.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 128
5.36 Celltrix AB Company Overview 129
5.36.1 Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 129
5.37 Clearbridge Health Ltd Company Overview 130
5.37.1 Clearbridge Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 130
5.38 ClearIt LLC Company Overview 131
5.38.1 ClearIt LLC Pipeline Products & Ongoing Clinical Trials Overview 131
5.39 Collplant Biotechnologies Ltd Company Overview 132
5.39.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 132
5.40 Cutera Inc Company Overview 134
5.40.1 Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 134
5.41 Cytrellis Biosystems Inc Company Overview 137
5.41.1 Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 137
5.42 Delft University of Technology Company Overview 140
5.42.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 140
5.43 Dexlevo Inc Company Overview 141
5.43.1 Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 141
5.44 Emory University Company Overview 142
5.44.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 142
5.45 EP Global Communications Inc (Inactive) Company Overview 143
5.45.1 EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 143
5.46 Erchonia Corp Company Overview 144
5.46.1 Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 144
5.47 Establishment Labs SA Company Overview 147
5.47.1 Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 147
5.48 Eternity Healthcare Inc Company Overview 162
5.48.1 Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 162
5.49 EternoGen Aesthetics LLC Company Overview 163
5.49.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 163
5.50 Fillmed Laboratoires Company Overview 164
5.50.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 164
5.51 FixNip Ltd Company Overview 170
5.51.1 FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 170
5.52 Florida International University Company Overview 173
5.52.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 173
5.53 Forticell Bioscience Inc Company Overview 174
5.53.1 Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 174
5.54 Fourth State Medicine Ltd Company Overview 175
5.54.1 Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 175
5.55 G2GBIO Inc Company Overview 176
5.55.1 G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 176
5.56 Galderma SA Company Overview 177
5.56.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 177
5.57 GC Aesthetics Plc Company Overview 178
5.57.1 GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 178
5.58 Genial Light Co Ltd Company Overview 179
5.58.1 Genial Light Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 179
5.59 Genzyme Corp Company Overview 180
5.59.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 180
5.60 Giant Biogene Holding Co Ltd Company Overview 181
5.60.1 Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 181
5.61 Hallura Ltd Company Overview 184
5.61.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 184
5.62 HansBiomed Co Ltd Company Overview 188
5.62.1 HansBiomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 188
5.63 Healshape SAS Company Overview 191
5.63.1 Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 191
5.64 Histogen Inc Company Overview 192
5.64.1 Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 192
5.65 Hugel Inc Company Overview 193
5.65.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 193
5.66 Ilooda Co Ltd Company Overview 197
5.66.1 Ilooda Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 197
5.67 ImpLite Ltd. Company Overview 198
5.67.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 198
5.68 InMode Ltd Company Overview 199
5.68.1 InMode Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.69 Innova Medical Design Company Overview 202
5.69.1 Innova Medical Design Pipeline Products & Ongoing Clinical Trials Overview 202
5.70 Innovia LLC Company Overview 203
5.70.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 203
5.71 Intuitive Surgical Inc Company Overview 205
5.71.1 Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 205
5.72 Inventage Lab Inc Company Overview 206
5.72.1 Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 206
5.73 Jointechlabs Inc Company Overview 209
5.73.1 Jointechlabs Inc Pipeline Products & Ongoing Clinical Trials Overview 209
5.74 Juvenis Ltd Company Overview 210
5.74.1 Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 210
5.75 Khorionyx SA Company Overview 211
5.75.1 Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 211
5.76 Lattice Medical Company Overview 212
5.76.1 Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 212
5.77 LG Chem Ltd Company Overview 215
5.77.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 215
5.78 LifeCell Corp Company Overview 224
5.78.1 LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 224
5.79 LifeSprout Inc Company Overview 226
5.79.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 226
5.80 LigthSense Israel Ltd Company Overview 230
5.80.1 LigthSense Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 230
5.81 Lineage Cell Therapeutics Inc Company Overview 233
5.81.1 Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 233
5.82 ManaMed Inc Company Overview 235
5.82.1 ManaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 235
5.83 Medality Medical LLC Company Overview 236
5.83.1 Medality Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 236
5.84 Medifirst Solutions Inc Company Overview 239
5.84.1 Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 239
5.85 Medytox Inc Company Overview 240
5.85.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 240
5.86 Mentor Worldwide LLC Company Overview 243
5.86.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 243
5.87 Merz North America Inc Company Overview 244
5.87.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 244
5.88 Merz Pharma GmbH & Co KgaA Company Overview 247
5.88.1 Merz Pharma GmbH & Co KgaA Pipeline Products & Ongoing Clinical Trials Overview 247
5.89 Mesoestetic Pharma Group SL Company Overview 249
5.89.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 249
5.90 Moma Therapeutics Inc Company Overview 253
5.90.1 Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 253
5.91 N8 Medical LLC Company Overview 254
5.91.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 254
5.92 NanoVibronix Inc Company Overview 255
5.92.1 NanoVibronix Inc Pipeline Products & Ongoing Clinical Trials Overview 255
5.93 Neosthetic, LLC Company Overview 256
5.93.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 256
5.94 NivaSonix, LLC Company Overview 257
5.94.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 257
5.95 Northwestern University Company Overview 258
5.95.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 258
5.96 Nu Skin International Inc. Company Overview 259
5.96.1 Nu Skin International Inc. Pipeline Products & Ongoing Clinical Trials Overview 259
5.97 Oligo Medic Inc Company Overview 261
5.97.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 261
5.98 Oxtex Ltd (Inactive) Company Overview 262
5.98.1 Oxtex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 262
5.99 Pantec Biosolutions AG Company Overview 264
5.99.1 Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 264
5.100 PB&B SA Company Overview 265
5.100.1 PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 265
5.101 PetVivo Holdings Inc Company Overview 266
5.101.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 266
5.102 Philips Healthcare Company Overview 268
5.102.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 268
5.103 PhotoDerma SA Company Overview 271
5.103.1 PhotoDerma SA Pipeline Products & Ongoing Clinical Trials Overview 271
5.104 PhotoMedex Inc Company Overview 273
5.104.1 PhotoMedex Inc Pipeline Products & Ongoing Clinical Trials Overview 273
5.105 PhotoSonix Medical, Inc. Company Overview 275
5.105.1 PhotoSonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 275
5.106 Pinnacle Therapeutics Company Overview 276
5.106.1 Pinnacle Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 276
5.107 Plcoskin Company Overview 277
5.107.1 Plcoskin Pipeline Products & Ongoing Clinical Trials Overview 277
5.108 PolyNovo Biomaterials Pty Ltd Company Overview 278
5.108.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 278
5.109 Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Company Overview 281
5.109.1 Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 281
5.110 Prayasta 3D Inventions Pvt Ltd Company Overview 282
5.110.1 Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 282
5.111 PS Advanced Engineering Company Overview 283
5.111.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 283
5.112 Q-Med AB Company Overview 285
5.112.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 285
5.113 Recros Medica Inc Company Overview 290
5.113.1 Recros Medica Inc Pipeline Products & Ongoing Clinical Trials Overview 290
5.114 Revance Therapeutics Inc Company Overview 295
5.114.1 Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 295
5.115 Samyang Biopharmaceuticals Corp Company Overview 296
5.115.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 296
5.116 SANUWAVE Health Inc Company Overview 301
5.116.1 SANUWAVE Health Inc Pipeline Products & Ongoing Clinical Trials Overview 301
5.117 Sebana Medical Ltd Company Overview 304
5.117.1 Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 304
5.118 Shanghai Haohai Biological Technology Co Ltd Company Overview 305
5.118.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 305
5.119 Shin Poong Pharm Co Ltd Company Overview 307
5.119.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 307
5.120 Sienna Biopharmaceuticals Inc (Inactive) Company Overview 308
5.120.1 Sienna Biopharmaceuticals Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 308
5.121 Sientra Inc Company Overview 311
5.121.1 Sientra Inc Pipeline Products & Ongoing Clinical Trials Overview 311
5.122 Sihuan Pharmaceutical Holdings Group Ltd Company Overview 312
5.122.1 Sihuan Pharmaceutical Holdings Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 312
5.123 Silk Medical Aesthetics Inc Company Overview 313
5.123.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 313
5.124 Sinclair Pharma Ltd Company Overview 317
5.124.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 317
5.125 Slender Medical Ltd. Company Overview 321
5.125.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 321
5.126 SMSbiotech Inc Company Overview 323
5.126.1 SMSbiotech Inc Pipeline Products & Ongoing Clinical Trials Overview 323
5.127 Sofregen Medical Inc Company Overview 324
5.127.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 324
5.128 SofWave Medical Ltd Company Overview 327
5.128.1 SofWave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 327
5.129 Soliton Inc Company Overview 331
5.129.1 Soliton Inc Pipeline Products & Ongoing Clinical Trials Overview 331
5.130 Southern Illinois University Carbondale Company Overview 338
5.130.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 338
5.131 SunMax Biotechnology Co Ltd Company Overview 339
5.131.1 SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 339
5.132 Symatese Aesthetics Company Overview 344
5.132.1 Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 344
5.133 TEI Biosciences Inc Company Overview 347
5.133.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 347
5.134 Tempo Therapeutics Inc Company Overview 348
5.134.1 Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 348
5.135 Tensive SRL Company Overview 349
5.135.1 Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview 349
5.136 Teoxane SA Company Overview 352
5.136.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 352
5.137 Tetratherix Pty Ltd Company Overview 356
5.137.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 356
5.138 TeVido BioDevices LLC Company Overview 357
5.138.1 TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 357
5.139 Tissue Regeneration Technologies LLC Company Overview 358
5.139.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 358
5.140 Tissueform Inc Company Overview 359
5.140.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 359
5.141 University of California Irvine Company Overview 360
5.141.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 360
5.142 University of California Santa Barbara Company Overview 361
5.142.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 361
5.143 University of Missouri Company Overview 362
5.143.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 362
5.144 University of Pittsburgh Company Overview 363
5.144.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 363
5.145 University of Texas at Austin Company Overview 364
5.145.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 364
5.146 Uronext LLC Company Overview 366
5.146.1 Uronext LLC Pipeline Products & Ongoing Clinical Trials Overview 366
5.147 Venus Concept Inc (Inactive) Company Overview 367
5.147.1 Venus Concept Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 367
5.148 Wuhan Tianshiwei Holdings Co Ltd Company Overview 371
5.148.1 Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 371
5.149 Zeltiq Aesthetics Inc Company Overview 372
5.149.1 Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 372
5.150 Zift Medical LLC Company Overview 379
5.150.1 Zift Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 379
6 Aesthetic Devices- Recent Developments 382
6.1 Oct 07, 2022: Allergan Aesthetics to present data from its leading aesthetic portfolio at the 2022 American Society for Dermatologic Surgery Meeting 382
6.2 Oct 07, 2022: Agile Therapeutics Announces Reorganization of Leadership Team 383
6.3 Oct 06, 2022: Plus Therapeutics to Announce Third Quarter 2022 Financial Results and Host Conference Call on October 20, 2022 384
6.4 Oct 05, 2022: Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results 384
6.5 Oct 03, 2022: Venus Concept Announces Appointment of Rajiv De Silva as Chief Executive Officer and Director; Updates Fiscal Year 2022 Revenue Guidance 384
6.6 Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations 385
6.7 Sep 27, 2022: Flex hires Maryrose Sylvester to board of directors 386
6.8 Sep 09, 2022: Breast Implants: Reports of Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Implants: FDA Safety Communication 387
6.9 Sep 07, 2022: Glo Pharma Appoints Bluemercury Co-founder Marla Beck to Its Board of Directors 388
6.10 Sep 06, 2022: Evolus Announces Inducement Grants for New Chief Financial Officer 389
6.11 Sep 01, 2022: American Shared Hospital Services Strengthens Management Team with Appointment of Peter Gaccione as Chief Operating Officer 389
6.12 Aug 29, 2022: Revision Skincare announces strategic partnership with RVL Pharmaceuticals 390
6.13 Aug 26, 2022: Shanghai Haohai Biological Technology Announcement of Interim Results for the Six-month Period Ended 30 June 2022 391
6.14 Aug 25, 2022: Galderma Delivers Strong H1 2022 Results and Continued Innovation Across Its Leading Dermatology Portfolio 403
6.15 Aug 25, 2022: Sofwave to Showcase SUPERB (Synchronous Ultrasound Parallel Beam Technology) Live and In-Person at 5CC International Aesthetic Medical and Dermatology Conference 405
6.16 Aug 23, 2022: Hamilton Thorne Reports Financial and Operational Results for the Quarter and Six Months Ended June 30, 2022 406
6.17 Aug 16, 2022: Sofwave Medical Reports First Half Financial Results and Business Highlights 406
6.18 Aug 16, 2022: Hamilton Thorne to Announce Q2 Financial Results and Hold Conference Call on August 23, 2022 408
6.19 Aug 15, 2022: SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update 408
6.20 Aug 15, 2022: Ra Medical Systems Reports Second Quarter 2022 Financial Results 409
6.21 Aug 12, 2022: American Shared Hospital Services Reports
12.5% Period-over-Period Increase in Second Quarter 2022 Revenue 411
6.22 Aug 12, 2022: Venus Concept Announces Second Quarter of Fiscal Year 2022 Financial Results; Updates Fiscal Year 2022 Revenue Guidance 413
6.23 Aug 11, 2022: Biolase Delivers 34% Revenue Growth Year Over Year in Second Quarter 415
6.24 Aug 11, 2022: Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update 416
6.25 Aug 11, 2022: NanoVibronix announce quarter ended June 30, 2022 418
6.26 Aug 10, 2022: GLO Pharma Appoints Rothy’s CFO Dayna Quanbeck to Its Board of Directors 419
6.27 Aug 08, 2022: Sanuwave Closes $12 Million Capital Raise 420
6.28 Aug 03, 2022: Anika Reports Second Quarter Fiscal 2022 Financial Results 420
6.29 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results 423
6.30 Jul 27, 2022: Hamilton Thorne to Present at Canaccord Genuity 42nd Annual Growth Conference 423
6.31 Jul 27, 2022: Bausch Health Companies will Release Second-Quarter 2022 Financial Results on Aug. 9 424
6.32 Jul 27, 2022: Flex Reports First Quarter Fiscal 2023 Results 424
6.33 Jul 25, 2022: BIOLASE expands intellectual property portfolio with new United States and foreign patents 425
6.34 Jul 25, 2022: EC Healthcare expects sales volume to increase no less than 17% Y-o-Y to no less than HK$860 million in the first quarter 425
6.35 Jul 21, 2022: Plus Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights 426
6.36 Jul 17, 2022: Viora appoints Sergio Blumenblat as Vice President of Sales 428
6.37 Jul 13, 2022: Plus Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on July 21, 2022 428
6.38 Jul 12, 2022: Hamilton Thorne Appoints Francesco Fragasso as CFO 428
6.39 Jul 12, 2022: Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 429
6.40 Jul 07, 2022: Crown Laboratories Announces Expanded Role for Chief Financial Officer, Nadeem Moiz 429
6.41 Jul 06, 2022: Modulim announces intent to drive value-based care in nephrology market with custom Limb Preservation Solution 429
6.42 Jun 30, 2022: Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022 430
6.43 Jun 30, 2022: Haohai Biotechnology Announcement the Appointment of Senior Management and Securities Affairs Representatives 430
6.44 Jun 29, 2022: Shanghai Haohai Biological Technology Co. Announces Poll Results of Annual General Meeting and Distribution of Final Dividend for 2021 431
6.45 Jun 29, 2022: New clinical study demonstrates colorescience All Calm regimen neutralizes redness and calms inflamed skin 431
6.46 Jun 21, 2022: Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation 432
6.47 Jun 21, 2022: Bryant Wong Named Sciton Chief Financial Officer 432
6.48 Jun 16, 2022: Bausch Health provides update on Solta Medical 433
6.49 Jun 15, 2022: Hamilton Thorne Announces Annual and Special Meeting Voting Results 433
6.50 Jun 14, 2022: MedX Health adds new board member 434
6.51 Jun 13, 2022: Plus Therapeutics Reports Positive Clinical Outcomes from ReSPECT-GBM Trial at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting 435
6.52 Jun 13, 2022: Shanghai Haohai Biological Technology announces Supplemental Notice of 2021 Annual General Meeting 435
6.53 Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference 436
6.54 Jun 09, 2022: BIOLASE announces inaugural clinical excellence forum 436
6.55 Jun 03, 2022: Merz Aesthetics presents data at the IMCAS World Congress 2022 437
6.56 May 25, 2022: Colorescience reveals clinical study results of the finishing touch skincare protocol following facial radiofrequency microneedling procedures 438
6.57 May 24, 2022: Cutera Announces Proposed Private Offering of $200 Million of Convertible Senior Notes 438
6.58 May 19, 2022: Shanghai Haohai Biological Technology Notice of 2021 Annual General Meeting 440
6.59 May 19, 2022: Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2022 440
6.60 May 16, 2022: Zimmer Biomet Announces Appointment of New Chief Accounting Officer 442
6.61 May 16, 2022: Ra Medical Systems Reports First Quarter 2022 Financial Results 442
6.62 May 12, 2022: Biolase Maintains Growth Momentum as First Quarter Revenue Increased 25% Year Over Year 443
6.63 May 12, 2022: Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results Reaffirms Fiscal Year 2022 Revenue Guidance 445
6.64 May 11, 2022: Hamilton Thorne to Announce Q4 and Year End 2021 Financial Results and Hold Conference Call on May 19, 2022 446
6.65 May 10, 2022: Novanta Announces Financial Results for the First Quarter 2022 447
6.66 May 10, 2022: Modulim Announces Appointment of Healthcare Technology Industry Veteran Carl St. Bernard to Board of Directors 450
6.67 May 10, 2022: Cutera Announces Record First Quarter 2022 Revenue Results 451
6.68 May 10, 2022: Simulated Inanimate Models, announces the achievement of two new Milestones 452
6.69 May 10, 2022: Hamilton Thorne Announces annual and special meeting 453
6.70 May 09, 2022: Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022 453
6.71 May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022 454
6.72 May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results 454
6.73 May 04, 2022: Dyve Biosciences to Present at the UBS Global Healthcare Conference 457
6.74 May 04, 2022: Flex releases Q4 and fiscal 2022 results 458
6.75 May 03, 2022: Zimmer Biomet Announces First Quarter 2022 Financial Results 459
6.76 May 02, 2022: InMode Reports First Quarter 2022 Financial Results 460
6.77 May 02, 2022: MedX Health Announces 2021 Year End Results 462
6.78 Apr 29, 2022: Bausch Health Will Release First-Quarter 2022 Financial Results On May 10 463
6.79 Apr 28, 2022: PHC Holdings Benoemt Shoji Miyazaki tot Chief Executive Officer 463
6.80 Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update 463
6.81 Apr 21, 2022: Plus Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights 465
6.82 Apr 21, 2022: Establishment Labs Notes presentation of 2-year results from Motiva US IDE Study at The Aesthetic Meeting 2022 466
6.83 Apr 19, 2022: Modulim Announces New Vice President of Marketing 467
6.84 Apr 14, 2022: Plus Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on April 21, 2022 467
6.85 Apr 11, 2022: InMode Expects First Quarter 2022 Revenue Between $85.0-$85.5M, Non-GAAP Earnings per Diluted Share Between $0.38-$0.39 468
6.86 Apr 07, 2022: Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2021 469
6.87 Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022 471
6.88 Apr 06, 2022: Endymed Expands Its Operation in North America; Welcomes Bill Scott as Endymed’s US Subsidiary President 471
6.89 Apr 06, 2022: PatientFi expands partnership with Allergan Aesthetics 472
6.90 Apr 05, 2022: Galderma launches a virtual experience this Rosacea Awareness Month showcasing how the condition goes beyond the visible with Rosacea Space 472
6.91 Apr 04, 2022: MedX Health signs commercial distribution agreement with Vitamed Biomedical to launch Medx’s teledermatology screening platform in Italy 473
6.92 Apr 04, 2022: Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022 474
6.93 Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference 474
6.94 Mar 31, 2022: Hamilton Thorne to Announce Q4 and Year End 2021 Financial Results and Hold Conference Call on April 7, 2022 474
6.95 Mar 31, 2022: Smith & Nephew announces Directorate Change 474
6.96 Mar 30, 2022: Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update 475
6.97 Mar 28, 2022: Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results Introduces Fiscal Year 2022 Revenue Guidance 477
6.98 Mar 23, 2022: Biolase to Participate in Maxim Group’s 2022 Virtual Growth Conference Hosted by M-Vest on March 28th – 30th 479
6.99 Mar 23, 2022: Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results 479
6.100 Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference 481
6.101 Mar 09, 2022: Sofwave Medical reports financial results for the full year 2021 with accelerated growth in revenues and gross margin 481
6.102 Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results 483
6.103 Mar 07, 2022: Smith & Nephew Announces Notice of Annual General Meeting 484
6.104 Mar 07, 2022: Smith & Nephew Notice of 85th Annual General Meeting 484
6.105 Mar 03, 2022: Plus Therapeutics Announces Upcoming Participation at the 2022 SNMMI Therapeutics Conference 486
6.106 Mar 01, 2022: Sisram Medical : Voluntary announcement 487
6.107 Feb 27, 2022: Shanghai Haohai Biological Technology announcement of preliminary annual results for the year 2021 487
6.108 Feb 24, 2022: Plus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights 488
6.109 Feb 23, 2022: Ourself, the first-ever subtopical skincare system, launches to provide clinical-level results without the clinic 489
6.110 Feb 22, 2022: Flex appoints Becky Sidelinger as president of reliability solutions 490
6.111 Feb 22, 2022: Cutera Announces Fourth Quarter and Full-Year 2021 Financial Results Along With 2022 Outlook 491
6.112 Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer 492
6.113 Feb 18, 2022: Plus Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 24, 2022 495
6.114 Feb 17, 2022: Hamilton Thorne Announces Record Revenue for the Quarter and Year Ended December 31 2021 495
6.115 Feb 08, 2022: Venus Concept to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16th 496
6.116 Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022 497
6.117 Feb 07, 2022: Zimmer Biomet Announces Fourth Quarter and Full-Year 2021 Financial Results 497
6.118 Feb 07, 2022: Flex Announces New Presidents of Health Solutions and Consumer Devices Business Units 498
6.119 Feb 03, 2022: Bausch Health Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 498
6.120 Feb 03, 2022: Bausch Health Companies Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 499
6.121 Feb 02, 2022: Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022 499
6.122 Jan 27, 2022: Flex hires Patrick Ward to board of directors 499
6.123 Jan 26, 2022: Flex announces results for Q3 ended December 31, 2021 500
6.124 Jan 21, 2022: Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of ZimVie; ZimVie to Host Investor Day on February 7 500
6.125 Jan 21, 2022: Elevai Labs announces global distribution partnership with premier aesthetic device company Dermapenworld 501
6.126 Jan 20, 2022: Acellular dermal matrix products used in breast reconstruction 501
6.127 Jan 18, 2022: Hamilton Thorne Appoints Karen Firestone to Board of Directors 503
6.128 Jan 13, 2022: NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors 503
6.129 Jan 11, 2022: Bausch Health Will Provide Business And Strategic Update At The 40th Annual JP Morgan Healthcare Conference 504
6.130 Jan 10, 2022: Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue 504
6.131 Jan 05, 2022: Bausch health to participate at the 40th annual J.P. Morgan healthcare conference 505
6.132 Jan 05, 2022: Evolus Expands Board of Directors With Appointment of Digital and Beauty Innovator Brady Stewart 505
6.133 Jan 05, 2022: Biolase to present at the h.C. Wainwright bioconnect virtual investor conference 505
6.134 Jan 04, 2022: FibroGen to Present at H.C. Wainwright Bioconnect Virtual Conference 506
6.135 Jan 04, 2022: ENDYMED appoints Dr. Ziv Karni, Founder of Alma Lasers as Expert Technology Advisor 506
6.136 Dec 14, 2021: AVITA Medical Announces Adjournment of 2021 Annual Stockholder Meeting 506
6.137 Dec 09, 2021: Aspen Laser awarded U.S. General Services Administration (GSA) contract 507
6.138 Nov 29, 2021: MedX Health Announces Third Quarter 2021 Results 508
6.139 Nov 22, 2021: Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended September 30 2021 510
6.140 Nov 18, 2021: Zimmer Biomet to Present at Evercore ISI’s 4th Annual HealthCONx Conference 511
6.141 Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences 511
6.142 Nov 17, 2021: Hamilton Thorne to Present at Stifel and Piper Sandler Conferences 512
6.143 Nov 17, 2021: Silk Medical Aesthetics announces feasibility clinical trial results for its all-natural dermal filler 512
6.144 Nov 16, 2021: New integrated scanner for additive manufacturing, Firefly 3D 513
6.145 Nov 15, 2021: Hamilton Thorne to Announce Q3 2021 Financial Results and Hold Conference Call on November 22, 2021 513
6.146 Nov 15, 2021: Ra Medical Systems Reports 2021 Third Quarter Financial Results 514
6.147 Nov 12, 2021: Venus Concept Announces Third Quarter and First Nine Months of 2021 Financial Results; Updates Fiscal Year 2021 Revenue Guidance 516
6.148 Nov 10, 2021: BIOLASE Reports 46% Revenue Growth In 2021 Third Quarter 518
6.149 Nov 10, 2021: Venus Concept to Participate in the Stifel 2021 Virtual Healthcare Conference 518
6.150 Nov 09, 2021: Evolus Announces Participation in November Investment Conferences 518
6.151 Nov 09, 2021: FibroGen Reports Third Quarter 2021 Financial Results 519
6.152 Nov 04, 2021: Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance 520
6.153 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results 521
6.154 Nov 03, 2021: Zimmer Biomet to Present at Stifel’s 2021 Virtual Healthcare Conference 524
6.155 Nov 02, 2021: Evolus Reports Third Quarter 2021 Results and Provides Business Update 524
6.156 Nov 02, 2021: Bausch Health Companies Announces Third-Quarter 2021 Results 526
6.157 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors 527
6.158 Oct 28, 2021: Shanghai Haohai Biological Tech Announces 2021 Third Quarterly Report 527
6.159 Oct 27, 2021: FDA strengthens safety requirements and updates study results for breast implants 528
6.160 Oct 26, 2021: Establishment Labs to Announce Third Quarter 2021 Financial Results on November 9 529
6.161 Oct 26, 2021: FibroGen to Report Third Quarter 2021 Financial Results 529
6.162 Oct 21, 2021: Plus Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights 530
6.163 Oct 19, 2021: Sientra and Mission Plasticos launch reshaping lives: Full Circle a philanthropic initiative for women living in poverty in America 531
6.164 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021 532
7 Appendix 533
7.1 Methodology 533
7.2 About GlobalData 536
7.3 Contact Us 536
7.4 Disclaimer 536
List of Tables
Aesthetic Devices – Pipeline Products by Stage of Development 32
Aesthetic Devices – Pipeline Products by Segment 33
Aesthetic Devices – Pipeline Products by Territory 35
Aesthetic Devices – Pipeline Products by Regulatory Path 37
Aesthetic Devices – Pipeline Products by Estimated Approval Date 38
Aesthetic Devices – Ongoing Clinical Trials 39
Aesthetic Devices Companies – Pipeline Products by Stage of Development 40
Aesthetic Devices – Pipeline Products by Stage of Development 46
3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 53
3D Printed Breast Implant – Lupectomy Reconstruction – Product Status 53
3D Printed Breast Implant – Lupectomy Reconstruction – Product Description 53
AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Hyaluronic Acid Filler – Jawline – Product Status 54
Hyaluronic Acid Filler – Jawline – Product Description 54
Hyaluronic Acid Filler – Skin – Product Status 55
Hyaluronic Acid Filler – Skin – Product Description 55
Accure Acne Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Accure Laser – Product Status 56
Accure Laser – Product Description 56
Acoustiic Inc Pipeline Products & Ongoing Clinical Trials Overview 57
High Intensity Focused Ultrasound Device – Product Status 57
High Intensity Focused Ultrasound Device – Product Description 57
Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
ACROFILL – Product Status 58
ACROFILL – Product Description 58
Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Algeness DF – Product Status 59
Algeness DF – Product Description 59
Algeness HD – Product Status 60
Algeness HD – Product Description 60
Algeness LD – Product Status 60
Algeness LD – Product Description 61
Algeness VL – Product Status 61
Algeness VL – Product Description 61
Advanced Aesthetic Technologies Inc – Ongoing Clinical Trials Overview 62
Algeness VL – A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds 63
Algeness VL – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 63
Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 64
BioDermal Filler – Product Status 64
BioDermal Filler – Product Description 64
Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 65
Alluris – Product Status 65
Alluris – Product Description 65
Skinlumina – Product Status 66
Skinlumina – Product Description 66
SkinTechMD – Product Status 66
SkinTechMD – Product Description 67
Aesthetics BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
Vivace Ultra – Product Status 68
Vivace Ultra – Product Description 68
Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69
Juvence Implant – Product Status 69
Juvence Implant – Product Description 69
AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
Smooth Shell AeroForm Tissue Expander System – Product Status 70
Smooth Shell AeroForm Tissue Expander System – Product Description 70
Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 71
AAM SubQ Body Filler – Product Status 71
AAM SubQ Body Filler – Product Description 72
ADM Subdermal Body Filler – Product Status 72
ADM Subdermal Body Filler – Product Description 72
Elastagen – Acne Scars – Product Status 72
Elastagen – Acne Scars – Product Description 73
Elastagen – Skin Quality – Product Status 73
Elastagen – Skin Quality – Product Description 73
Eplica Silk – Product Status 73
Eplica Silk – Product Description 74
HA Threads – Product Status 74
HA Threads – Product Description 74
Inspira TF2 – Breast Augmentation – Product Status 74
Inspira TF2 – Breast Augmentation – Product Description 75
Juvederm – Decolletage – Product Status 75
Juvederm – Decolletage – Product Description 75
Juvederm – Hands – Product Status 75
Juvederm – Hands – Product Description 76
Juvederm – Neck Lines – Product Status 76
Juvederm – Neck Lines – Product Description 76
Juvederm RejuveCross – Deep Wrinkles – Product Status 76
Juvederm RejuveCross – Deep Wrinkles – Product Description 77
Juvederm RejuveCross – Etched Lines Wrinkles – Product Status 77
Juvederm RejuveCross – Etched Lines Wrinkles – Product Description 77
Juvederm RejuveCross Volumize – Cheek Augmentation – Product Status 77
Juvederm RejuveCross Volumize – Cheek Augmentation – Product Description 78
Juvederm Voluma – Nose – Product Status 78
Juvederm Voluma – Nose – Product Description 78
Juvederm Voluma – Temple – Product Status 78
Juvederm Voluma – Temple – Product Description 79
Juvederm Voluma Global – Malar Augmentation – Product Status 79
Juvederm Voluma Global – Malar Augmentation – Product Description 79
Larger Inspira TE – Product Status 79
Larger Inspira TE – Product Description 80
Phoenix – Breast Augmentation – Product Status 80
Phoenix – Breast Augmentation – Product Description 80
rhCollagen Dermal Filler – Product Status 80
rhCollagen Dermal Filler – Product Description 81
rhCollagen Soft Tissue Filler – Product Status 81
rhCollagen Soft Tissue Filler – Product Description 81
SeriGel – Product Status 82
SeriGel – Product Description 82
Skin Quattro Device – Product Status 82
Skin Quattro Device – Product Description 83
Allergan Aesthetics – Ongoing Clinical Trials Overview 84
Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 85
Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 85
Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 86
Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
Hyaluronic Acid Facial Filler – Product Status 87
Hyaluronic Acid Facial Filler – Product Description 87
Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 88
Ambulight Rejuvenate – Product Status 88
Ambulight Rejuvenate – Product Description 88
AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 89
Next Generation Laser – Product Status 89
Next Generation Laser – Product Description 89
Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 90
DefyGravity – Product Status 90
DefyGravity – Product Description 90
Apyx Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 91
Apyx Plasma/RF Handpiece – Skin Laxity Procedures – Product Status 91
Apyx Plasma/RF Handpiece – Skin Laxity Procedures – Product Description 92
Renuvion APR Handpiece – Product Status 92
Renuvion APR Handpiece – Product Description 92
Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 93
Breast Prosthesis – Product Status 93
Breast Prosthesis – Product Description 93
Asymmetric Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
Asymmetric Laser Tool – Product Status 94
Asymmetric Laser Tool – Product Description 94
Bausch Health Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 95
SOF – 010: Skin Resurfacing – Product Status 95
SOF – 010: Skin Resurfacing – Product Description 95
SOM – 010: Vascular Lesions – Product Status 96
SOM – 010: Vascular Lesions – Product Description 96
SOT – 010: Fine Lines & wrinkles – Product Status 96
SOT – 010: Fine Lines & wrinkles – Product Description 96
SOT – 011: Fine Lines & Wrinkles – Product Status 97
SOT – 011: Fine Lines & Wrinkles – Product Description 97
XUA – 001: Hair Removal – Product Status 97
XUA – 001: Hair Removal – Product Description 97
Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 98
Endo Laser – Product Status 98
Endo Laser – Product Description 98
Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
ECM Composite Collagen – Product Status 99
ECM Composite Collagen – Product Description 99
Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 100
Complex Collagen Filler (Type III) – Product Status 100
Complex Collagen Filler (Type III) – Product Description 100
First Generation PLLA Filler (Type III) – Product Status 101
First Generation PLLA Filler (Type III) – Product Description 101
Second Generation PCL Filler (Type III) – Product Status 101
Second Generation PCL Filler (Type III) – Product Description 102
BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 103
Senella Scaffold – Product Status 103
Senella Scaffold – Product Description 103
BellaSeno GmbH – Ongoing Clinical Trials Overview 104
Senella Scaffold – Clinical Trial Evaluating Feasibility and Safety of Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation with Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery 105
BellaSeno Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 106
3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Status 106
3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Description 106
BellaSeno Pty Ltd – Ongoing Clinical Trials Overview 107
3D Printed Pectus Scaffold Implant – Pectus Excavatum – A Clinical Trial Evaluating Medical-Grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage 108
Bimini Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 109
Dermapose Fat Removal and Transfer System – Product Status 109
Dermapose Fat Removal and Transfer System – Product Description 109
Kerastem – Product Status 110
Kerastem – Product Description 110
Puregraft Boost Adipose Micronizer – Product Status 110
Puregraft Boost Adipose Micronizer – Product Description 111
Puregraft Microfat – Product Status 111
Puregraft Microfat – Product Description 111
BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112
Biological Breast – Product Status 112
Biological Breast – Product Description 112
Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 113
Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 113
Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 113
Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 114
Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
Airbrush Liposculptor IIE – Product Status 115
Airbrush Liposculptor IIE – Product Description 115
Airbrush Liposculptor IIIE – Product Status 116
Airbrush Liposculptor IIIE – Product Description 116
Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 117
BioBreast Scaffold – Product Status 117
BioBreast Scaffold – Product Description 117
Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 118
Cytosmile – Product Status 118
Cytosmile – Product Description 118
MTI-12 – Product Status 119
MTI-12 – Product Description 119
MTI-12 – Surgical Repair – Product Status 119
MTI-12 – Surgical Repair – Product Description 120
BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 121
SGA300 – Product Status 121
SGA300 – Product Description 121
SGA302 – Product Status 122
SGA302 – Product Description 122
SGA320 – Product Status 122
SGA320 – Product Description 123
Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
BMI4002 – Product Status 124
BMI4002 – Product Description 124
Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 125
Next Gen Greenlight Fiber System – Product Status 125
Next Gen Greenlight Fiber System – Product Description 125
Starfire Laser – Product Status 126
Starfire Laser – Product Description 126
Candela Corp Pipeline Products & Ongoing Clinical Trials Overview 127
Pneumatic Skin Fattening For Telangectasia – Product Status 127
Pneumatic Skin Fattening For Telangectasia – Product Description 127
CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 128
Lipage – Product Status 128
Lipage – Product Description 128
Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 129
Credurance – Product Status 129
Credurance – Product Description 129
Clearbridge Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 130
Nanofibrous Scaffold – Product Status 130
Nanofibrous Scaffold – Product Description 130
ClearIt LLC Pipeline Products & Ongoing Clinical Trials Overview 131
ERASER System – Product Status 131
ERASER System – Product Description 131
Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 132
3D-Breast Implant – Product Status 132
3D-Breast Implant – Product Description 132
Dermal Filler – Product Status 133
Dermal Filler – Product Description 133
Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 134
enlighten Multi-Wavelength – Tattoo Removal – Product Status 134
enlighten Multi-Wavelength – Tattoo Removal – Product Description 134
Cutera Inc – Ongoing Clinical Trials Overview 135
enlighten Multi-Wavelength – Tattoo Removal – A Multi-center Pilot Study of a Novel Multi-wavelength Laser for Tattoo Removal 136
Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 137
Micro-Excision Device – Product Status 137
Micro-Excision Device – Product Description 137
Cytrellis Biosystems Inc – Ongoing Clinical Trials Overview 138
Micro-Excision Device – A Prospective, Multi-center, Pilot Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-coring Device for the Treatment of Scars 139
Micro-Excision Device – A Prospective, Multi-center, Pivotal Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles 139
Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 140
DPS Controlled Laser Coagulation Needle – Product Status 140
DPS Controlled Laser Coagulation Needle – Product Description 140
Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 141
Gouri – Product Status 141
Gouri – Product Description 141
Emory University Pipeline Products & Ongoing Clinical Trials Overview 142
Nasolabial Fold Implant – Product Status 142
Nasolabial Fold Implant – Product Description 142
EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 143
MEMS Nerve Ablation Device – Facial Glabellar Frowning – Product Status 143
MEMS Nerve Ablation Device – Facial Glabellar Frowning – Product Description 143
Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 144
Erchonia HLS Laser – Product Status 144
Erchonia HLS Laser – Product Description 144
Erchonia ML Scanner – Female Hair Restoration – Product Status 145
Erchonia ML Scanner – Female Hair Restoration – Product Description 145
Erchonia ML Scanner – Venous Stasis Ulcers – Product Status 145
Erchonia ML Scanner – Venous Stasis Ulcers – Product Description 146
Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 147
Mia Femtech – Product Status 147
Mia Femtech – Product Description 148
Motiva Ergonomix – Product Status 148
Motiva Ergonomix – Product Description 148
Motiva Ergonomix2 – Product Status 149
Motiva Ergonomix2 – Product Description 149
Motiva Ergonomix2 Diamond Breast Implant – Product Status 149
Motiva Ergonomix2 Diamond Breast Implant – Product Description 150
Motiva Flora Tissue Expander – Product Status 150
Motiva Flora Tissue Expander – Product Description 150
Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Status 151
Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Description 151
Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Status 151
Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Description 152
Motiva MIA – Product Status 152
Motiva MIA – Product Description 152
Motiva Round – Product Status 153
Motiva Round – Product Description 153
SmoothSilk Anatomical Tissue Expander – Product Status 154
SmoothSilk Anatomical Tissue Expander – Product Description 154
Establishment Labs SA – Ongoing Clinical Trials Overview 155
Motiva Round – Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation 156
Motiva Round – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 156
Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 157
Motiva Ergonomix – Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation 158
Motiva Ergonomix – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 158
SmoothSilk Anatomical Tissue Expander – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 159
Motiva Flora Tissue Expander – Post-Marketing Clinical Follow-Up Study to Confirm the Safety and Effectiveness/Performance of Motiva Flora Tissue Expander in Staged Breast Reconstruction Surgery 160
Motiva Flora Tissue Expander – Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction 160
Motiva MIA – A Study to Evaluate the Motiva Mia System for Minimally Invasive Augmentation in Patients Undergoing Breast Implants 161
Motiva MIA – Multicenter Study to Evaluate Motiva Mia System for Minimally Invasive Augmentation in Thailand 161
Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 162
Hand-held Laser Hair Removal Device – Product Status 162
Hand-held Laser Hair Removal Device – Product Description 162
EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 163
Cellifique – Product Status 163
Cellifique – Product Description 163
Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 164
ART FILLER FINE LINES – Product Status 164
ART FILLER FINE LINES – Product Description 164
ART FILLER LIPS – Product Status 165
ART FILLER LIPS – Product Description 165
ART FILLER LIPS SOFT – Product Status 165
ART FILLER LIPS SOFT – Product Description 166
ART FILLER NASOLABIAL FOLDS – Product Status 166
ART FILLER NASOLABIAL FOLDS – Product Description 166
ART FILLER UNIVERSAL – Product Status 167
ART FILLER UNIVERSAL – Product Description 167
ART FILLER VOLUME – Product Status 167
ART FILLER VOLUME – Product Description 168
NCTF 135 – Product Status 168
NCTF 135 – Product Description 168
NCTF 135 HA – Product Status 169
NCTF 135 HA – Product Description 169
FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 170
FixNip NRI – Product Status 170
FixNip NRI – Product Description 170
FixNip Ltd – Ongoing Clinical Trials Overview 171
FixNip NRI – A Prospective, Open Label, Single Arm, Multicenter Study Evaluating the FixNip NRI Safety and Performance in Female Patients Seeking Reconstructive Surgery of the Nipple 172
Florida International University Pipeline Products & Ongoing Clinical Trials Overview 173
Cosmetic Skin Treatment Device – Product Status 173
Cosmetic Skin Treatment Device – Product Description 173
Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 174
Haptized Collagen Tissue Augmentation Device – Product Status 174
Haptized Collagen Tissue Augmentation Device – Product Description 174
Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 175
Nebulaskin – Product Status 175
Nebulaskin – Product Description 175
G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 176
GB-3001 – Product Status 176
GB-3001 – Product Description 176
Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 177
Biostimulator Filler – Product Status 177
Biostimulator Filler – Product Description 177
GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 178
PERLE – Product Status 178
PERLE – Product Description 178
Genial Light Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 179
Genial Bone Laser – Product Status 179
Genial Bone Laser – Product Description 179
Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 180
Prevelle Lift – Product Status 180
Prevelle Lift – Product Description 180
Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 181
Cross-Linking Recombinant Collagen Skin Rejuvenation Gel – Product Status 181
Cross-Linking Recombinant Collagen Skin Rejuvenation Gel – Product Description 181
Recombinant Collagen Skin Rejuvenation Gel – Product Status 182
Recombinant Collagen Skin Rejuvenation Gel – Product Description 182
Recombinant Collagen Sterile Dressing – Product Status 182
Recombinant Collagen Sterile Dressing – Product Description 183
Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 184
BiOLinkMatrix Gel – Product Status 184
BiOLinkMatrix Gel – Product Description 184
Hyaluronic Acid Dermal Filler – Product Status 185
Hyaluronic Acid Dermal Filler – Product Description 185
Hallura Ltd – Ongoing Clinical Trials Overview 186
BiOLinkMatrix Gel – Prospective, Interventional, Non-randomized, Open Label Study for the Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler 187
HansBiomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 188
Bellagel SmoothFine – Product Status 188
Bellagel SmoothFine – Product Description 188
HansBiomed Co Ltd – Ongoing Clinical Trials Overview 189
Bellagel SmoothFine – Clinical Trial to Evaluate the Safety and Efficacy of Cohesive Silicone Gel-filled Breast Implant (CoSBI) in Women Aged 22 and Over with Breast Reconstruction or Augmentation Mammoplasty 190
Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 191
3D Printed Breast Implant – Product Status 191
3D Printed Breast Implant – Product Description 191
Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 192
HST002 – Product Status 192
HST002 – Product Description 192
Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 193
The Chaeum Pure No.1 – Product Status 193
The Chaeum Pure No.1 – Product Description 194
The Chaeum Pure No.2 – Product Status 194
The Chaeum Pure No.2 – Product Description 194
The Chaeum Pure No.3 – Product Status 195
The Chaeum Pure No.3 – Product Description 195
The Chaeum Pure No.4 – Product Status 195
The Chaeum Pure No.4 – Product Description 196
The Chaeum Style – Product Status 196
The Chaeum Style – Product Description 196
Ilooda Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 197
reepot Nd; YAG Laser System – Product Status 197
reepot Nd; YAG Laser System – Product Description 197
ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 198
Freedom Implant – Product Status 198
Freedom Implant – Product Description 198
InMode Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
Trim II – Product Status 199
Trim II – Product Description 199
InMode Ltd – Ongoing Clinical Trials Overview 200
Trim II – Safety and Efficacy of Trim II for Non-invasive Lipolysis and Circumference Reduction of Abdomen 201
Innova Medical Design Pipeline Products & Ongoing Clinical Trials Overview 202
Aesthetic Injection – Product Status 202
Aesthetic Injection – Product Description 202
Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 203
Breast Implant Shell – Product Status 203
Breast Implant Shell – Product Description 203
Wrinkle Filler – Product Status 204
Wrinkle Filler – Product Description 204
Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 205
RF Laser Device – Product Status 205
RF Laser Device – Product Description 205
Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 206
IVL-MD-B001 – Product Status 206
IVL-MD-B001 – Product Description 206
IVL-MD-F001 – Product Status 207
IVL-MD-F001 – Product Description 207
IVL-MD-F002 – Product Status 207
IVL-MD-F002 – Product Description 208
Jointechlabs Inc Pipeline Products & Ongoing Clinical Trials Overview 209
Mini-Stem System – Product Status 209
Mini-Stem System – Product Description 209
Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 210
Tenergel – Product Status 210
Tenergel – Product Description 210
Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 211
Autologous Globin Dermal Filler – Product Status 211
Autologous Globin Dermal Filler – Product Description 211
Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 212
MATTISSE – Product Status 212
MATTISSE – Product Description 212
Lattice Medical – Ongoing Clinical Trials Overview 213
MATTISSE – First-in-human, Study of MATTISSE Tissue Engineering Chamber in Adult Female Patients Undergoing Immediate Breast Reconstruction After Mastectomy for Cancer 214
LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 215
LR19059 – Product Status 215
LR19059 – Product Description 215
LR19093 – Product Status 216
LR19093 – Product Description 216
LR20008 – Product Status 216
LR20008 – Product Description 216
LR20024 – Product Status 217
LR20024 – Product Description 217
YVOIRE Y-Solution 360 – Product Status 217
YVOIRE Y-Solution 360 – Product Description 218
YVOIRE Y-Solution 540 – Product Status 218
YVOIRE Y-Solution 540 – Product Description 218
YVOIRE Y-Solution 720 – Product Status 219
YVOIRE Y-Solution 720 – Product Description 219
LG Chem Ltd – Ongoing Clinical Trials Overview 220
YVOIRE Y-Solution 360 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 221
YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 221
YVOIRE Y-Solution 540 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 222
YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 222
YVOIRE Y-Solution 720 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 223
YVOIRE Y-Solution 720 – A Multicenter, Randomized, Evaluator-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring 223
YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 223
LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 224
Artia – Breast Reconstruction – Product Status 224
Artia – Breast Reconstruction – Product Description 224
Strattice Reconstructive Tissue Matrix – Face Lift – Product Status 225
Strattice Reconstructive Tissue Matrix – Face Lift – Product Description 225
LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 226
Injectable Nanofiber-Hydrogel Matrix – Product Status 226
Injectable Nanofiber-Hydrogel Matrix – Product Description 226
Lumina – Product Status 227
Lumina – Product Description 227
LifeSprout Inc – Ongoing Clinical Trials Overview 228
Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 229
LigthSense Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 230
S2 Picosecond Laser – Product Status 230
S2 Picosecond Laser – Product Description 230
LigthSense Israel Ltd – Ongoing Clinical Trials Overview 231
S2 Picosecond Laser – A Single-center, Open-label, Uncontrolled Pilot Study to Evaluate the Safety and Efficacy of S2 – Multi-wavelength Laser for Tattoo Removal 232
Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 233
Renevia – Product Status 233
Renevia – Product Description 234
ManaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 235
FB Professional LED Red Light Therapy System – Product Status 235
FB Professional LED Red Light Therapy System – Product Description 235
Medality Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 236
HydraSolve T2D – Product Status 236
HydraSolve T2D – Product Description 236
Medality Medical LLC – Ongoing Clinical Trials Overview 237
HydraSolve T2D – Evaluation of the Removal of Excess Intra-abdominal Fat in Subjects with Type 2 Diabetes and Obesity, Using the HydraSolve T2D System, on Glucose Control, Insulin Resistance and Body Weight 238
Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 239
Green Laser – 532 nm – Product Status 239
Green Laser – 532 nm – Product Description 239
Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 240
MT943 – Product Status 240
MT943 – Product Description 240
Neuramis Deep Lidocaine – Product Status 241
Neuramis Deep Lidocaine – Product Description 241
Neuramis Volume Lidocaine – Product Status 241
Neuramis Volume Lidocaine – Product Description 242
Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 243
Mentor – Becker Round Adjustable Gel Implant – Product Status 243
Mentor – Becker Round Adjustable Gel Implant – Product Description 243
Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 244
VP1 Lido US – Product Status 244
VP1 Lido US – Product Description 244
Merz North America Inc – Ongoing Clinical Trials Overview 245
VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 246
Merz Pharma GmbH & Co KgaA Pipeline Products & Ongoing Clinical Trials Overview 247
BioGlue Surgical Adhesive For Mid-Face Lifts – Product Status 247
BioGlue Surgical Adhesive For Mid-Face Lifts – Product Description 247
BioGlue Surgical Adhesive For Nose And Eyelid Surgeries – Product Status 248
BioGlue Surgical Adhesive For Nose And Eyelid Surgeries – Product Description 248
Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 249
LIFT001 – Product Status 249
LIFT001 – Product Description 249
mRDX-02-17 – Product Status 250
mRDX-02-17 – Product Description 250
Mesoestetic Pharma Group SL – Ongoing Clinical Trials Overview 251
LIFT001 – Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid 252
Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 253
Restogel – 131 – Product Status 253
Restogel – 131 – Product Description 253
N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 254
Ceragenin-Infused Dermal Filler – Product Status 254
Ceragenin-Infused Dermal Filler – Product Description 254
NanoVibronix Inc Pipeline Products & Ongoing Clinical Trials Overview 255
Renooskin – Product Status 255
Renooskin – Product Description 255
Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 256
Neosthetic Breast Implant – Product Status 256
Neosthetic Breast Implant – Product Description 256
NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 257
NivaSonix ULLISYS – Product Status 257
NivaSonix ULLISYS – Product Description 257
Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 258
Mammary Prosthesis – Product Status 258
Mammary Prosthesis – Product Description 258
Nu Skin International Inc. Pipeline Products & Ongoing Clinical Trials Overview 259
ageLOC Epsilon – Product Status 259
ageLOC Epsilon – Product Description 259
Next Generation Home-Use Skin Care Device – Product Status 260
Next Generation Home-Use Skin Care Device – Product Description 260
Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 261
AntaRep – Product Status 261
AntaRep – Product Description 261
Oxtex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 262
Oxtex Tissue Expander – Cosmetic Surgery – Product Status 262
Oxtex Tissue Expander – Cosmetic Surgery – Product Description 262
Oxtex Tissue Expander – Reconstructive Surgery – Product Status 263
Oxtex Tissue Expander – Reconstructive Surgery – Product Description 263
Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 264
P.L.E.A.S.E. Mobile – Product Status 264
P.L.E.A.S.E. Mobile – Product Description 264
PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 265
PB&B Facial Volumizer – Product Status 265
PB&B Facial Volumizer – Product Description 265
PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 266
CosmetaLife – Product Status 266
CosmetaLife – Product Description 266
Dermal Filler – Lip – Product Status 267
Dermal Filler – Lip – Product Description 267
Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 268
Sunstone IPL Device – Product Status 268
Sunstone IPL Device – Product Description 268
Philips Healthcare – Ongoing Clinical Trials Overview 269
Sunstone IPL Device – Clinical Investigation of Safety and Efficacy of a Philips Intense Pulsed Light Device for Hair Reduction (Sunstone 2019) 270
PhotoDerma SA Pipeline Products & Ongoing Clinical Trials Overview 271
Photodynamic Therapy Device – Acne – Product Status 271
Photodynamic Therapy Device – Acne – Product Description 271
Photodynamic Therapy Device – Hair Removal – Product Status 272
Photodynamic Therapy Device – Hair Removal – Product Description 272
PhotoMedex Inc Pipeline Products & Ongoing Clinical Trials Overview 273
Omnilux Micro – Product Status 273
Omnilux Micro – Product Description 273
Omnilux Nano – Product Status 274
Omnilux Nano – Product Description 274
PhotoSonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 275
CLENS System – Product Status 275
CLENS System – Product Description 275
Pinnacle Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 276
AcuShape – Product Status 276
AcuShape – Product Description 276
Plcoskin Pipeline Products & Ongoing Clinical Trials Overview 277
3D Printed Breast Implant – Product Status 277
3D Printed Breast Implant – Product Description 277
PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 278
NovoSling – Product Status 278
NovoSling – Product Description 278
NovoSorb – Breast Augmentation – Product Status 279
NovoSorb – Breast Augmentation – Product Description 279
NovoSorb – Breast Reconstruction – Product Status 279
NovoSorb – Breast Reconstruction – Product Description 280
Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 281
Matrix Medical Aesthetic Robot – Product Status 281
Matrix Medical Aesthetic Robot – Product Description 281
Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 282
Silicone-Based Breast Prosthesis – Product Status 282
Silicone-Based Breast Prosthesis – Product Description 282
PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 283
Laser LED Hybrid Anti-acne Device – Product Status 283
Laser LED Hybrid Anti-acne Device – Product Description 283
Panelized Anti Wrinkle Platform – Product Status 284
Panelized Anti Wrinkle Platform – Product Description 284
Radiofrequency Anti-aging Device – Product Status 284
Radiofrequency Anti-aging Device – Product Description 284
Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 285
GAL1906 – Product Status 285
GAL1906 – Product Description 285
GP0112 – Product Status 286
GP0112 – Product Description 286
Q-Med AB – Ongoing Clinical Trials Overview 287
GAL1906 – A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area 288
GP0112 – A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies 289
Recros Medica Inc Pipeline Products & Ongoing Clinical Trials Overview 290
Nuvellus – Lipectomy Cannula – Product Status 290
Nuvellus – Lipectomy Cannula – Product Description 290
Nuvellus – Multi-Scalpet Array – Product Status 291
Nuvellus – Multi-Scalpet Array – Product Description 291
Nuvellus – Single Scalpet – Product Status 291
Nuvellus – Single Scalpet – Product Description 292
Nuvellus Rotational Fractional Resection System – Product Status 292
Nuvellus Rotational Fractional Resection System – Product Description 292
Recros Medica Inc – Ongoing Clinical Trials Overview 293
Nuvellus Rotational Fractional Resection System – The INFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring with an Optimized Post-procedure Treatment Plan 294
Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 295
RHA Redensity – Product Status 295
RHA Redensity – Product Description 295
Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 296
Aesthetic Filler – Product Status 296
Aesthetic Filler – Product Description 296
Croquis – Product Status 297
Croquis – Product Description 297
SYB Filler (SF-01) – Product Status 297
SYB Filler (SF-01) – Product Description 298
Samyang Biopharmaceuticals Corp – Ongoing Clinical Trials Overview 299
SYB Filler (SF-01) – A Randomized, Subject and Evaluator-blind, Matched Pairs, Prospective Study to Compare the Safety and Efficacy Between SYB Filler (SF-01) and Ellanse M in the Correction of Nasolabial Folds 300
SANUWAVE Health Inc Pipeline Products & Ongoing Clinical Trials Overview 301
Profile – Product Status 301
Profile – Product Description 301
SANUWAVE PACE – Cellulite – Product Status 302
SANUWAVE PACE – Cellulite – Product Description 302
SANUWAVE PACE – Scars – Product Status 302
SANUWAVE PACE – Scars – Product Description 303
Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 304
Dermal Filler – Product Status 304
Dermal Filler – Product Description 304
Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 305
Organic Cross-Linked HA Dermal Filler – Product Status 305
Organic Cross-Linked HA Dermal Filler – Product Description 305
QST Gel – Product Status 306
QST Gel – Product Description 306
Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 307
FreeWink – Product Status 307
FreeWink – Product Description 307
Sienna Biopharmaceuticals Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 308
SNA-001 (1064 nm) – Product Status 308
SNA-001 (1064 nm) – Product Description 308
SNA-001 (755 nm) – Product Status 309
SNA-001 (755 nm) – Product Description 309
SNA-001 – Skin Rejuvenation – Product Status 309
SNA-001 – Skin Rejuvenation – Product Description 310
Sientra Inc Pipeline Products & Ongoing Clinical Trials Overview 311
Next-Generation Allox2 Tissue Expander – Product Status 311
Next-Generation Allox2 Tissue Expander – Product Description 311
Sihuan Pharmaceutical Holdings Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 312
PHA Microsphere – Product Status 312
PHA Microsphere – Product Description 312
Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 313
Dermal Filler – Product Status 313
Dermal Filler – Product Description 313
SMA-001 – Product Status 314
SMA-001 – Product Description 314
Silk Medical Aesthetics Inc – Ongoing Clinical Trials Overview 315
Dermal Filler – A Feasibility Clinical Trial of All-natural Dermal Filler for Nasolabial Folds 316
Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 317
Atlean – Product Status 317
Atlean – Product Description 317
Ellanse Lidocaine – Product Status 318
Ellanse Lidocaine – Product Description 318
MaiLi – Product Status 318
MaiLi – Product Description 319
Perfectha G – Product Status 319
Perfectha G – Product Description 319
Perfectha Lips – Product Status 320
Perfectha Lips – Product Description 320
Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 321
Ultrasound Body Shaping Device – Product Status 321
Ultrasound Body Shaping Device – Product Description 321
Ultrasound Device – Skin Rejuvenation – Product Status 322
Ultrasound Device – Skin Rejuvenation – Product Description 322
SMSbiotech Inc Pipeline Products & Ongoing Clinical Trials Overview 323
PEC-6C – Product Status 323
PEC-6C – Product Description 323
Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 324
Silk Protein – Tissue/Dermal Filler – Product Status 324
Silk Protein – Tissue/Dermal Filler – Product Description 324
Sofregen Medical Inc – Ongoing Clinical Trials Overview 325
Silk Protein – Tissue/Dermal Filler – A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler 326
SofWave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 327
SofWave System – Product Status 327
SofWave System – Product Description 327
SofWave Medical Ltd – Ongoing Clinical Trials Overview 328
SofWave System – A Single Center, Blinded, Split-Body, Randomized Clinical Trial of High Intensity Ultrasound for the Treatment of Upper Inner Arm Skin Laxity 329
SofWave System – Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement 329
SofWave System – Safety and Efficacy of Sofwave Treatment for Improvement of Cellulite Appearance 329
SofWave System – Safety and Efficacy of Sofwave Treatment to Lift Upper Arm Lax Skin 330
Soliton Inc Pipeline Products & Ongoing Clinical Trials Overview 331
RESONIC Device – Fibrotic Scars – Product Status 331
RESONIC Device – Fibrotic Scars – Product Description 331
RESONIC Device – Generation 2 – Product Status 332
RESONIC Device – Generation 2 – Product Description 332
RESONIC Device – Generation 3 – Product Status 332
RESONIC Device – Generation 3 – Product Description 333
RESONIC Device – Liver Fibrosis – Product Status 333
RESONIC Device – Liver Fibrosis – Product Description 333
RESONIC Device – Skin Laxity – Product Status 334
RESONIC Device – Skin Laxity – Product Description 334
RESONIC Device – Subcutaneous Fat Reduction – Product Status 334
RESONIC Device – Subcutaneous Fat Reduction – Product Description 335
Soliton Inc – Ongoing Clinical Trials Overview 336
RESONIC Device – Fibrotic Scars – Soliton’s Rapid Acoustic Pulse (RAP) Device for the Treatment of Fibrotic Scars: Multi-treatment Proof-of-concept Study 337
Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 338
Syringe System – Product Status 338
Syringe System – Product Description 338
SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 339
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Status 339
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Description 339
Sunmax FULLSGEN With Lidocaine – Product Status 340
Sunmax FULLSGEN With Lidocaine – Product Description 340
SunMax Biotechnology Co Ltd – Ongoing Clinical Trials Overview 341
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 342
Sunmax FULLSGEN With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 343
Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 344
ESTYME MATRIX Silicone Gel-Filled Breast Implant – Product Status 344
ESTYME MATRIX Silicone Gel-Filled Breast Implant – Product Description 344
Symatese Aesthetics – Ongoing Clinical Trials Overview 345
ESTYME MATRIX Silicone Gel-Filled Breast Implant – Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME MATRIX Round and Anatomical Silicone Gel-filled Breast Implants in the Breast Augmentation and Reconstruction – EMMIE Study 346
ESTYME MATRIX Silicone Gel-Filled Breast Implant – Evaluation of the Safety and Performance of Symatese Aesthetics Estyme Matrix Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation, Primary Intention (EMMA Study) 346
TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 347
Injectable Dermal Filler – Product Status 347
Injectable Dermal Filler – Product Description 347
Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 348
MAP Tissue Scaffold-Based Dermal Filler – Product Status 348
MAP Tissue Scaffold-Based Dermal Filler – Product Description 348
Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview 349
REGENERA Breast Implant – Product Status 349
REGENERA Breast Implant – Product Description 349
Tensive SRL – Ongoing Clinical Trials Overview 350
REGENERA Breast Implant – A Pilot Study of REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy – Long-term Follow-up 351
Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 352
Next Generation Dermal Filler – Product Status 352
Next Generation Dermal Filler – Product Description 352
Teosyal RHA 1 – Product Status 353
Teosyal RHA 1 – Product Description 353
Teoxane SA – Ongoing Clinical Trials Overview 354
Teosyal RHA 1 – A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA 1 355
Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 355
Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 356
Tetrafill – Product Status 356
Tetrafill – Product Description 356
TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 357
3D Printed Breast Implant – Product Status 357
3D Printed Breast Implant – Product Description 357
Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 358
DermaGold 100 – Cellulite – Product Status 358
DermaGold 100 – Cellulite – Product Description 358
Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 359
PureVoluma – Product Status 359
PureVoluma – Product Description 359
University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 360
Skin Rejuvenation Device – Product Status 360
Skin Rejuvenation Device – Product Description 360
University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 361
Needle Free Injector – Product Status 361
Needle Free Injector – Product Description 361
University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 362
Collagen-Based Dermal Filler – Product Status 362
Collagen-Based Dermal Filler – Product Description 362
University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 363
Push-To-Spin – Product Status 363
Push-To-Spin – Product Description 363
University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 364
Hypervascular Laser Device – Product Status 364
Hypervascular Laser Device – Product Description 364
Ultrashort-Pulsed Laser Device – Product Status 365
Ultrashort-Pulsed Laser Device – Product Description 365
Uronext LLC Pipeline Products & Ongoing Clinical Trials Overview 366
Alloy Penile Prosthesis – Product Status 366
Alloy Penile Prosthesis – Product Description 366
Venus Concept Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 367
Venus Aime – Product Status 367
Venus Aime – Product Description 367
Venus Aime – Tissue Excision – Product Status 368
Venus Aime – Tissue Excision – Product Description 368
Venus Concept Inc (Inactive) – Ongoing Clinical Trials Overview 369
Venus Aime – Clinical Evaluation of the Safety and Efficacy of Aime Robotic Mechanical Coring Device for the Treatment of Moderate to Severe Facial Wrinkles 370
Venus Aime – Pilot Study for the Clinical Evaluation of Mechanical Coring to Achieve Directional Skin Tightening 370
Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 371
Soluble Microneedle Device – Product Status 371
Soluble Microneedle Device – Product Description 371
Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 372
CoolSculpting – Cellulite – Product Status 372
CoolSculpting – Cellulite – Product Description 373
CoolSculpting – Pseudogynecomastia – Product Status 373
CoolSculpting – Pseudogynecomastia – Product Description 373
CoolSculpting COM-2 – Product Status 374
CoolSculpting COM-2 – Product Description 374
CoolSculpting COM-2.5 Device – Product Status 374
CoolSculpting COM-2.5 Device – Product Description 375
CoolSculpting COM-3 – Product Status 375
CoolSculpting COM-3 – Product Description 375
CoolSculpting Cryo RF Device – Product Status 376
CoolSculpting Cryo RF Device – Product Description 376
CoolSculpting EMS Device – Product Status 376
CoolSculpting EMS Device – Product Description 377
CoolSculpting Mini V2 – Product Status 377
CoolSculpting Mini V2 – Product Description 377
Zeltiq Applicator – Acne – Product Status 377
Zeltiq Applicator – Acne – Product Description 378
Zift Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 379
ZiftLift System – Brow-Lift Surgery – Product Status 379
ZiftLift System – Brow-Lift Surgery – Product Description 379
Zift Medical LLC – Ongoing Clinical Trials Overview 380
ZiftLift System – Brow-Lift Surgery – Evaluation of Patient and Physician Satisfaction with the Zift Elevation of Facial Tissue Clinical Study 381
Glossary 535
List of Figures
Aesthetic Devices – Pipeline Products by Stage of Development 31
Aesthetic Devices – Pipeline Products by Segment 32
Aesthetic Devices – Pipeline Products by Territory 34
Aesthetic Devices – Pipeline Products by Regulatory Path 36
Aesthetic Devices – Pipeline Products by Estimated Approval Date 38
Aesthetic Devices – Ongoing Clinical Trials 39
Frequently Asked Questions
The US, Europe, China, South Korea, Canada, Australia, Israel, Singapore, Brazil, and Japan are some of the key territories with products in the pipeline.
The key segments in the aesthetic devices pipeline products market are hyaluronic acid fillers, aesthetic injectables, aesthetic laser, implants, dermal filler, non-invasive body contouring devices, breast implants, shaped gel implants, high-intensity focused ultrasound (HIFU) devices, and acne device.
Some of the key regulatory paths followed by the aesthetic devices pipeline products market are 510(k), CE, PMA, NMPA, NIFDS, MDL, TGA, MDITAC, HSA, and ANVISA.
The key companies in the aesthetic devices pipeline products market are 3D Bio Corp, AbbVie Inc, Accure Acne Inc, Acoustiic Inc, Acro Biomedical Co Ltd, Advanced Aesthetic Technologies Inc, Aeon Astron Corporation, Aesthetic Medical Device, Aesthetics BioMedical, Inc., and Aesthetics Point Ltd.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Still undecided about purchasing this report?
Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.